Dexelvucitabine
- Generic Name
- Dexelvucitabine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C9H10FN3O3
- CAS Number
- 134379-77-4
- Unique Ingredient Identifier
- KU8SPJ271W
- Background
Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.
- Associated Conditions
- -
- Associated Therapies
- -
Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs
Phase 2
Terminated
- Conditions
- Interventions
- First Posted Date
- 2006-03-09
- Last Posted Date
- 2018-08-23
- Lead Sponsor
- Incyte Corporation
- Target Recruit Count
- 250
- Registration Number
- NCT00300573
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath